Elevated expression of METTL1/WDR4 mediates m7G tRNA modification, activates the WNT/β-catenin pathway, and promotes EMT and chemoresistance to cisplatin and docetaxel in nasopharyngeal carcinoma (NPC) cells [169]. Here, METTL1 is linked to nasopharyngeal carcinoma.